Trading at under 80 per cent of book value. With a growth profile as big as Xero. It also makes profit and has no competition. Wow
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025